Personalizing Medication Management with Pharmacogenetic Testing (PGT) in Mental Health
Title: Personalizing Medication Management with Pharmacogenetic Testing (PGT) in Mental Health
Date: Thursday, February 16, 2017
Time: 10:00 AM Pacific Daylight Time
Duration: 1 hour, 1 minute
Objectives: Upon completion of this session participants will be able to:
- Explain how genetic variability may influence medication efficacy and toxicity
- Discuss how genetic variations may allow clinicians to more effectively understand medication response
- Understand how PGT may provide valuable, objective information for more personalized therapy in mental health
Adam Rzetelny, Ph.D.
Dr. Rzetelny is a licensed clinical psychologist and Associate Director of Clinical Affairs at Millennium Health. He has more than 15 years of experience as a researcher, clinician, and educator in areas including addiction, psychiatry, and pain. He has treated severe mental illness in hospital settings and authored peer-reviewed publications and chapters on topics including clinical drug testing, and pharmacogenetics. Dr. Rzetelny has lectured extensively around the nation and supervised a federally funded lab investigating pharmacogenetics of nicotine dependence at Southern Illinois University at Carbondale. His post-doctoral training at Memorial Sloan Kettering Cancer Center in New York exposed him to clinical cases at the cross roads of cancer pain and addiction.